ArticleJournal for immunotherapy of cancer2019

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function.

Shiran Hoogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.